Dopamine-transporter density in patients with ADHD.
Baughman
F A
FA
D000328:Adult; D001289:Attention Deficit Disorder with Hyperactivity / Q000000981:diagnostic imaging* / Q000188:drug therapy* / Q000473:pathology; D002352:Carrier Proteins / Q000187:drug effects*; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D015259:Dopamine Agents / Q000627:therapeutic use*; D050483:Dopamine Plasma Membrane Transport Proteins; D006801:Humans; D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins; D009419:Nerve Tissue Proteins; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D012107:Research Design / Q000592:standards*; D015899:Tomography, Emission-Computed, Single-Photon
D002352:Carrier Proteins; D000697:Central Nervous System Stimulants; D015259:Dopamine Agents; D050483:Dopamine Plasma Membrane Transport Proteins; D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins; D009419:Nerve Tissue Proteins; D011619:Psychotropic Drugs